The White House is reviewing a long-awaited FDA proposed rule that would help switch more prescription drugs to over-the-counter status, which HHS and a key industry group say could help lower health care costs. FDA sent the proposal to the White House Office of Management and Budget for review Thursday (March 10). OTC industry group the Consumer Healthcare Products Association told Inside Health Policy it’s pleased FDA is moving forward on the regulation, which has been years in the...